Healthcare stocks are moderately higher, with the NYSE
Healthcare Sector Index gaining about 0.2% and shares of healthcare
companies in the S&P 500 rising 0.1% as a group.
In company news, CollabRx (
) is up more than 15% at $4.85 a share, earlier streaking to a new
52-week high of $6.75 after announcing a multi-year, non-exclusive
agreement to supply medical annotations to Quest Diagnostics (
) for its new sequencing test services for cancer.
The service was developed by CLRX and customized for use by DGX.
Under the agreement, DGX has the right to incorporate medical
content, such as scientific literature, medical guidelines and
published therapeutic protocols into its sequencing cancer tests.
It also will have the right to incorporate CLRX content into
clinical-trial services performed for its pharmaceutical
Financial terms of the agreement were not disclosed. DGX shares
are ahead 0.5% at $63.61 each.
In other sector news,
(+) VPHM, (+25.5%) Agrees to $4.2 billion buyout from Shire plc
), with shareholders receiving $50 per share in cash. SHPG shares
also are 0.3% higher.
(-) MDRX, (-0.6%) Reports Q3 adjusted earnings of $0.05 per
share, trailing analyst estimates by $0.03. Revenue declined 8.6%
year over year to $330 million, missing the FactSet consensus call
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.